Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring.

[1]  K. Eagle,et al.  Recurrent ischemia across the spectrum of acute coronary syndromes: prevalence and prognostic significance of (re-)infarction and ST-segment changes in a large contemporary registry. , 2010, International journal of cardiology.

[2]  E. Braunwald,et al.  Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. , 2009, Journal of the American College of Cardiology.

[3]  I. Anand.  Heart failure and anemia: mechanisms and pathophysiology , 2008, Heart Failure Reviews.

[4]  M. Zahid,et al.  Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome. , 2007, The American journal of cardiology.

[5]  A. Yan,et al.  Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome. , 2007, American heart journal.

[6]  F. Zijlstra,et al.  Value of routine admission laboratory tests to predict thirty-day mortality in patients with acute myocardial infarction. , 2006, The American journal of cardiology.

[7]  Sunil V. Rao,et al.  Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions , 2006, Journal of Thrombosis and Thrombolysis.

[8]  J. Gore,et al.  Bleeding complications in patients with anemia and acute myocardial infarction. , 2005 .

[9]  Randall C. Thompson,et al.  Relation of anemia at discharge to survival after acute coronary syndromes. , 2005, The American journal of cardiology.

[10]  R. Giugliano,et al.  Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[11]  A. Voors,et al.  Hemoglobin levels and 30-day mortality in patients after myocardial infarction. , 2005, International journal of cardiology.

[12]  M. Krucoff,et al.  Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion. , 2004, Circulation.

[13]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[14]  J. J. Griffin,et al.  Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. , 2004, Journal of the American College of Cardiology.

[15]  Á. Avezum,et al.  Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[16]  P. Armstrong,et al.  Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide , 2003 .

[17]  C. Falcone,et al.  Increased production of inflammatory cytokines in patients with silent myocardial ischemia. , 2001, Journal of the American College of Cardiology.

[18]  M. Simoons,et al.  Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. , 2001, European heart journal.

[19]  H. Krumholz,et al.  Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[20]  M. Cohen,et al.  Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. , 2000, Journal of the American College of Cardiology.

[21]  R. Califf,et al.  Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. , 2000, American heart journal.

[22]  M. Nieminen,et al.  Relation of inflammation to vascular function in patients with coronary heart disease. , 2000, Atherosclerosis.

[23]  R. Califf,et al.  Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia , 1998 .

[24]  R. Ross,et al.  Atherosclerosis is an Inflammatory Disease , 1998 .

[25]  P. Levy,et al.  Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. , 1996, The Journal of trauma.

[26]  J. O’Keefe,et al.  Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. , 1995, Journal of the American College of Cardiology.

[27]  P. Armstrong,et al.  Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. , 1992, Journal of the American College of Cardiology.

[28]  M. Weisfeldt,et al.  Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. , 1988, JAMA.

[29]  D. Waters,et al.  Early postinfarction ischemia: clinical, angiographic, and prognostic significance. , 1987, Circulation.

[30]  H. Gewirtz,et al.  Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. , 1986, Circulation.